Citigroup Inc 23and Me Holding Co. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in 23and Me Holding Co. stock. As of the latest transaction made, Citigroup Inc holds 7,128 shares of ME stock, worth $27,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,128

Previous 49,591 85.63%

Holding current value

$27,371

Previous $19,000 89.47%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.29 - $0.51 $12,314 - $21,656	-42,463 Reduced 85.63%	7,128 $2,000
Q2 2024 Aug 12, 2024	SELL	$0.36 - $0.61 $14,934 - $25,306	-41,486 Reduced 45.55%	49,591 $19,000
Q1 2024 May 10, 2024	SELL	$0.4 - $0.91 $28,190 - $64,133	-70,476 Reduced 43.62%	91,077 $48,000
Q4 2023 Feb 09, 2024	BUY	$0.71 - $0.97 $98,780 - $134,954	139,128 Added 620.41%	161,553 $147,000
Q3 2023 Nov 09, 2023	SELL	$0.96 - $2.01 $84,373 - $176,656	-87,889 Reduced 79.67%	22,425 $21,000
Q2 2023 Aug 10, 2023	BUY	$1.59 - $2.29 $134,216 - $193,305	84,413 Added 325.91%	110,314 $193,000
Q1 2023 May 11, 2023	SELL	$2.05 - $2.87 $9,919 - $13,887	-4,839 Reduced 15.74%	25,901 $59,000
Q4 2022 Feb 09, 2023	SELL	$2.06 - $3.47 $7,201 - $12,131	-3,496 Reduced 10.21%	30,740 $66,000
Q3 2022 Nov 10, 2022	SELL	$2.6 - $5.12 $22,196 - $43,709	-8,537 Reduced 19.96%	34,236 $98,000
Q2 2022 Aug 10, 2022	BUY	$2.19 - $3.98 $1,587 - $2,885	725 Added 1.72%	42,773 $106,000
Q1 2022 May 12, 2022	SELL	$3.28 - $7.12 $12,536 - $27,212	-3,822 Reduced 8.33%	42,048 $161,000
Q4 2021 Feb 10, 2022	BUY	$6.55 - $13.25 $293,243 - $593,202	44,770 Added 4070.0%	45,870 $305,000
Q3 2021 Nov 10, 2021	BUY	$7.29 - $11.0 $8,019 - $12,100	1,100 New	1,100 $10,000

Others Institutions Holding ME

# of Institutions

116

Shares Held

82.5M

Call Options Held

404K

Put Options Held

292K

View Full List

About 23andMe Holding Co.

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $998M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

More about ME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account